You are here

  • Home
  • Archive
  • Volume 10, Issue Suppl 1
  • 12.03 ISB 1442, a first-in-class CD38 and CD47 bispecific antibody innate cell modulator for the treatment of CD38 positive hematological malignancies

Alerts

Article menu

Download PDFPDF

Oral Presentations
Plenary symposium 12: combination therapy (with a special focus on local IO)
12.03 ISB 1442, a first-in-class CD38 and CD47 bispecific antibody innate cell modulator for the treatment of CD38 positive hematological malignancies
Free
You need to be signed in to access email alerts. If you have an account log in with your user name and password. If you don't have an account you can just enter your email address in the email box below.
Sign In to Email Alerts with your Email Address